Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Non-Current Assets (2016 - 2025)

Palisade Bio has reported Non-Current Assets over the past 16 years, most recently at $123000.0 for Q4 2025.

  • Quarterly Non-Current Assets fell 68.13% to $123000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $791000.0 through Dec 2025, down 61.41% year-over-year, with the annual reading at $123000.0 for FY2025, 68.13% down from the prior year.
  • Non-Current Assets was $123000.0 for Q4 2025 at Palisade Bio, down from $145000.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $1.1 million in Q3 2022 and troughed at $92000.0 in Q1 2022.
  • The 5-year median for Non-Current Assets is $428500.0 (2022), against an average of $519516.2.
  • Year-over-year, Non-Current Assets tumbled 82.23% in 2021 and then soared 935.87% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $1.0 million in 2021, then rose by 2.39% to $1.0 million in 2022, then dropped by 29.71% to $724000.0 in 2023, then plummeted by 46.69% to $386000.0 in 2024, then plummeted by 68.13% to $123000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Non-Current Assets are $123000.0 (Q4 2025), $145000.0 (Q3 2025), and $220000.0 (Q2 2025).